InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Neal Walker, Director, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 11 open-market SEC Form 4 transactions: 0 purchases worth $0 and 11 sales worth $3.8M, reported from Feb 9, 22 to Mar 3, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 3, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 30.2K | $12.63 | $382K |
| Mar 2, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 29.0K | $12.37 | $359K |
| Feb 2, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 3.1K | $17.54 | $53K |
| Feb 1, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 25.0K | $16.75 | $419K |
| Jan 4, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 15.0K | $14.89 | $223K |
| Jan 3, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 23.4K | $16.16 | $355K |
| Apr 25, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 20.0K | $15.18 | $304K |
| Apr 22, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 25.0K | $15.04 | $376K |
| Apr 21, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 25.0K | $15.24 | $381K |
| Mar 11, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 56.3K | $15.91 | $896K |
| Feb 9, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 3.6K | $12.66 | $46K |